Many folks in NC can’t access Ozempic due to limited insurance coverage. But policy changes and falling prices may expand ...

Ozempic is the version of Novo Nordisk's semaglutide ... GLP-1 agonists have evolved into powerful tools for weight management and broader cardiometabolic health. Yet, as their use skyrockets ...

In the wake of early evidence supporting the long-term health benefits of GLP-1 based medications to potentially reduce the ...

A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...

The widespread adoption of GLP-1 (glucagon-like peptide-1) receptor agonist medications, such as Ozempic and Wegovy, is ...

GLP-1 drugs like Ozempic show widespread promise beyond weight loss/diabetes, but cost and supply limit broader adoption.

The high monthly costs of GLP-1s — ranging from $1,000 to $1,500 — are placing considerable financial pressure on healthcare ...

Denmark's Novo Nordisk faces mounting pressure — from cheap copycats to US tariff threats — putting its weight-loss empire at ...

Cardiovascular Benefits Insulin resistance is a major risk factor for cardiovascular disease. Studies have shown that Ozempic not only ... its potential as a broader metabolic health intervention.